{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:19:52Z","timestamp":1783210792943,"version":"3.54.6"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aims to analyze the use of sedative-hypnotic drugs among children and adolescents in a hospital setting, providing a reference for optimizing drug use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective analysis was conducted on the prescription data of sedative-hypnotic drugs for children and adolescents aged 6\u201318 years from 2018 to 2023\u00a0at the outpatient department of the hospital. Data were organized using Excel and analyzed using statistical software such as SPSS, with descriptive statistics and independent samples t-tests used to analyze medication patterns across different age groups and genders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The majority of prescriptions originated from the psychiatry department. The most common diagnoses included depressive state, anxiety state, and sleep disorders. Combination therapy with benzodiazepines and antidepressants was the most common treatment regimen. The number of prescriptions showed a yearly increasing trend, rising from 160 in 2018 to 1,583 in 2023, and the total usage also increased annually, from 30.47\u00a0g in 2018 to 260.15\u00a0g in 2023. Despite the increase in total usage, the drug usage per prescription decreased year by year. Most patients had a medication duration of less than 30 days, and the <jats:italic>per capita<\/jats:italic> usage increased with longer medication durations. Lorazepam and zopiclone were the most frequently used drugs. The study also found that the duration of medication use was significantly longer in female patients than in males, and significantly longer in the 6\u201312 age group compared to the 13\u201318 age group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The use of sedative-hypnotic drugs in children and adolescents has shown a yearly increasing trend, and the management of sedative-hypnotic drug use in children and adolescents should be strengthened.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1563580","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:24:18Z","timestamp":1744867458000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of sedative-hypnotic drug use trends in children and adolescents (2018\u20132023): a study based on outpatient prescription data from a general hospital"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhang","family":"Qingyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wenqing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hou","family":"Yanbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Pingping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Jiaxin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Dalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Kanzhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Junting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Zhenzhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruan","family":"Liemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Yunxin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"E208","DOI":"10.9778\/cmajo.20130076","article-title":"Use of benzodiazepines and related drugs in manitoba: a population-based study","volume":"2","author":"Alessi-Severini","year":"2014","journal-title":"Cmaj Open"},{"key":"B2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12887-023-04331-4","article-title":"Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment","volume":"23","author":"Antoniou","year":"2023","journal-title":"Bmc Pediatr."},{"key":"B3","first-page":"1467","article-title":"Trends in incident use of benzodiazepines and z-drugs in France from 2006 to 2012: a population-based study","volume-title":"Pharmacoepidemiol. Drug Saf","author":"B\u00e9nard-Laribi\u00e8re","year":"2017"},{"key":"B4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s40261-018-0648-y","article-title":"Translating benzodiazepine utilization data into meaningful population exposure: integration of two metrics for improved reporting","volume":"38","author":"Brandt","year":"2018","journal-title":"Clin. Drug Investig."},{"key":"B5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/add.16359","article-title":"Drug overdose risk with benzodiazepine treatment in young adults: comparative analysis in privately and publicly insured individuals","volume":"119","author":"Bushnell","year":"2024","journal-title":"Addiction"},{"key":"B6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/camh.12716","article-title":"Trends in the nonmedical misuse of benzodiazepines and z-hypnotics among school-aged adolescents (2016-2021): gender differences and related factors","volume":"29","author":"Carrasco-Garrido","year":"2024","journal-title":"Child. Adolesc. Ment. Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/tpsy.tpsy_18_21","article-title":"Prescription patterns and trends of anxiolytics and hypnotics\/sedatives among child and adolescent patients with psychiatric illnesses in a psychiatric center of northern taiwan","volume":"35","author":"Cheng","year":"2021","journal-title":"Taiwan. J. Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/arclin\/acx120","article-title":"The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis","volume":"33","author":"Crowe","year":"2018","journal-title":"Arch. Clin. Neuropsychol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.14009\/j.issn.1672-2124.2019.04.026","article-title":"Analysis of sedative-hypnotic drug use in 11 hospitals in Zhejiang Province from 2011 to 2016","volume":"19","author":"Ding","year":"2019","journal-title":"Eval. Analysis Drug-Use Hosp. China"},{"key":"B10","volume-title":"Report on the development of national mental health in China (2021-2022)","author":"Fu","year":"2023"},{"key":"B11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.psc.2023.06.008","article-title":"Pediatric insomnia","volume":"47","author":"Himelfarb","year":"2024","journal-title":"Psychiatr. Clin. North Am."},{"key":"B12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/pds.3825","article-title":"Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven european electronic healthcare databases: a cross-national descriptive study from the protect-eu project","volume":"25","author":"Huerta","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e295384","DOI":"10.1371\/journal.pone.0295384","article-title":"Time trends in self-reported depressive symptoms, prescription of antidepressants, sedatives and hypnotics and the emergence of social media among Norwegian adolescents","volume":"18","author":"Lien","year":"2023","journal-title":"Plos One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jpeds.2018.12.033","article-title":"A comparison of pediatric and adult safety studies for antipsychotic and antidepressant drugs submitted to the United States food and drug administration","volume":"208","author":"Liu","year":"2019","journal-title":"J. Pediatr."},{"key":"B15","volume-title":"Comprehensive prevention and treatment guidelines for insomnia disorders in","author":"Lu","year":"2019"},{"key":"B16","doi-asserted-by":"publisher","first-page":"zsae058","DOI":"10.1093\/sleep\/zsae058","article-title":"Insomnia medications for children, adolescents, and young adults: shedding light in the darkness","volume":"47","author":"McCall","year":"2024","journal-title":"Sleep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.jped.2015.08.006","article-title":"Insomnia in childhood and adolescence: clinical aspects, diagnosis, and therapeutic approach","volume":"91","author":"Nunes","year":"2015","journal-title":"J. Pediatr. Rio J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"Jama Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e14035","DOI":"10.1111\/jsr.14035","article-title":"The european insomnia guideline: an update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J. Sleep. Res."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002635","article-title":"Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: a total population register-linkage study","volume":"15","author":"Sidorchuk","year":"2018","journal-title":"PLOS Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3760\/cma.j.issn.0376-2491.2017.24.002","article-title":"Guidelines for the diagnosis and treatment of insomnia in China","volume":"97","author":"Society","year":"2017","journal-title":"Chin. Med. J. Engl."},{"key":"B21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.13683\/j.wph.2018.04.001","article-title":"Interpretation of the 2017 Chinese guidelines for the diagnosis and treatment of insomnia","volume":"39","author":"Su","year":"2018","journal-title":"World Clin. Drugs"},{"key":"B22","doi-asserted-by":"publisher","first-page":"727453","DOI":"10.3389\/fpsyt.2021.727453","article-title":"Trends in psychotropic medication prescriptions in urban China from 2013 to 2017: national population-based study","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.11669\/cpj.2023.10.010","article-title":"Analysis of the current status of psychotropic drug use among children in China","volume":"58","author":"Zhang","year":"2023","journal-title":"Chin. Pharm. J."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1563580\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:24:23Z","timestamp":1744867463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1563580\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":24,"alternative-id":["10.3389\/fphar.2025.1563580"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1563580","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"article-number":"1563580"}}